2018 Q2/Global Life Sciences



Changes in rank are compared to 2018 Q1/Global Life Sciences. Since then, 1 site entered the survey, 1 site left the survey and 63 sites could not be included in the rankings (5 more since last time).

Details

Scores

Percentage Failures




Rank Name Exact overall
+ 6 Cytogen 6.68
+ 1 Taisho Pharmaceutical 6.45
+ 1 Yakult UK 6.44
+ 18 Nissan Chemical 6.41
same Hetero 6.33
+ 72 Neurocrine Biosciences 6.06
+ 2 Wockhardt 6.04
+ 2 Genus 6.04
+ 32 Takeda 6.02
+ 13 Ligand Pharmaceuticals 5.95
+ 1 QLT 5.94
+ 7 Galenica AG 5.90
+ 3 Meda Pharmaceuticals 5.71
+ 12 Astellas Europe 5.66
- 9 Lilly 5.50
- 2 Actelion 5.48
+ 1 EISAI UK 5.45
- 5 Bayer Schering Pharma 5.42
+ 21 Debiopharm 5.38
+ 9 Vitrolife 5.36
+ 75 Takeda UK 5.34
+ 11 Lundbeck 5.34
- 3 BTG International 5.34
+ 1 Otsuka Pharmaceuticals Europe 5.31
+ 18 Zandu 5.30
+ 20 Toray Industries 5.25
+ 5 Kyorin Holdings 5.15
- 4 Julphar 5.14
+ 5 Baxter International 5.12
- 13 Vertex Pharmaceuticals 5.10
+ 6 Mitsubishi Tanabe Pharma Europe Ltd 5.08
+ 6 Abbott Uk 5.06
- 5 Bosnalijek 5.00
- 4 Nippon Chemiphar 4.99
+ 13 Akorn 4.96
+ 37 ProMetric Life Sciences 4.94
+ 2 Kissei 4.89
+ 15 Apotex 4.85
+ 175 Sanofi 4.80
+ 153 Genzyme 4.78
+ 3 Genmab 4.78
+ 40 Chugai - Pharma 4.77
+ 9 Abbott 4.76
+ 18 Pfizer UK 4.76
- 10 Recordati 4.75
- 1 Acorda Therapeutics 4.74
+ 8 Asahi Kasei 4.69
+ 32 Leo Pharma UK 4.65
+ 8 Sanofi UK 4.64
+ 10 Wockhardt UK 4.64
+ 16 Avanir Pharmaceuticals 4.64
+ 6 Intas Pharmaceuticals 4.64
+ 8 Diffusion Pharmaceuticals 4.63
- 33 Laboratoires Thea UK 4.62
- 5 Bial Portela 4.62
- 5 Mochida 4.61
+ 6 MediGene 4.59
+ 11 Leo Pharma 4.59
- 12 ALK-Abello 4.59
+ 16 United Therapeutics 4.57
- 19 Array BioPharma 4.56
+ 3 Impax Laboratories 4.56
+ 35 Perrigo 4.52
+ 35 Elan 4.52
- 11 GlaxoSmithKline 4.50
same Kaken Pharmaceutical 4.47
- 11 Otsuka Pharmaceuticals 4.47
same Regeneron 4.42
+ 133 Sawai Pharmaceutical 4.41
+ 21 Santen Europe 4.39
+ 92 Genzyme UK 4.38
- 13 Biotecnol 4.38
+ 11 Valeant Pharmaceuticals 4.37
+ 11 Valeant Europe 4.37
- 39 Hospira 4.36
- 4 Bavarian Nordic 4.36
- 62 Stallergenes 4.35
- 67 Pharmacosmos 4.34
- 52 Dainippon Sumitomo 4.34
- 5 Cipla 4.32
- 17 Boehringer Ingelheim 4.32
- 5 Bayer UK & Ireland 4.30
- 52 Lexicon Pharmaceuticals 4.27
- 3 Eskayef Bangladesh Ltd 4.25
+ 48 Santen 4.20
same Zentiva 4.20
- 13 Astrazeneca 4.14
+ 34 SOBI 4.14
same Esteve 4.14
+ 23 Daiichi-Sankyo 4.12
+ 29 Astellas 4.08
- 5 Hisamitsu 4.07
- 5 Boehringer Ingelheim UK 4.06
+ 11 Xoma 4.05
- 87 EISAI 4.04
- 6 Biotest 4.04
- 4 Stada 4.02
- 28 Melior Discovery 4.02
- 5 Meiji Holdings 4.01
- 3 Stallergenes UK 3.97
+ 29 Menarini 3.94
+ 90 Jazz Pharmaceuticals 3.94
same Hutchison China MediTech 3.90
+ 5 Fresenius Medical Care 3.90
+ 76 Kyowa Hakko Kirin 3.89
+ 10 Novartis 3.88
+ 30 The Medicines Co 3.87
+ 51 Aspen Pharmacare 3.87
- 8 Gilead Sciences 3.86
- 4 Menarini UK 3.84
+ 3 Orion Pharma 3.82
- 2 Faes Farma 3.80
- 34 Torrent Pharmacueticals 3.79
+ 24 Seikagaku 3.77
+ 30 Mitsubishi Tanabe 3.77
+ 3 Roche 3.76
+ 15 Merz 3.75
- 3 nLife Therapeutics 3.69
- 70 Servier 3.68
- 2 China Pharmaceutical Group 3.67
same Alexion Pharmaceuticals 3.64
+ 12 Laboratorios Farmaceuticos ROVI 3.64
same Towa Pharmaceutical 3.63
+ 1 Strides Arcolab 3.61
+ 1 Piramel Enterprises 3.61
- 34 Teijin Europe 3.60
+ 33 Ipsen 3.60
- 1 Shire 3.60
- 1 Medivation 3.59
+ 1 Endo Pharmaceuticals Inc. 3.56
- 24 Johnson & Johnson 3.54
- 49 Vernalis 3.50
+ 17 Roche UK 3.50
- 17 Anavex Life Sciences Corp 3.49
+ 20 Ferring 3.43
- 12 Ipsen UK 3.43
- 2 MorphoSys 3.43
- 2 Gruenenthal 3.42
same KRKA 3.40
same Anika Therapeutics 3.40
new Meda Pharmaceuticals UK 3.40
- 1 Mylan 3.38
same Senju Pharmaceutical 3.35
+ 14 Glenmark Pharmaceuticals Europe 3.35
+ 20 Dr Reddy's 3.35
+ 1 Pfizer 3.33
+ 2 Orchid Pharmaceuticals 3.28
- 4 Novartis UK 3.25
+ 2 Daiichi-Sankyo UK 3.21
- 39 Covence 3.20
- 39 Hikma Pharmaceuticals 3.20
+ 24 Amgen 3.19
+ 16 UCB 3.15
- 25 Galderma 3.15
+ 15 Biocon 3.14
- 4 Laboratoires Thea 3.11
+ 21 Nova Nordisk 3.10
+ 6 Alkaloid 3.10
- 3 Actavis 3.08
+ 8 Pharmstandard 3.06
+ 10 Italfaraco 3.01
+ 10 Nova Nordisk UK 3.00
+ 16 Aptalis Pharma 2.98
+ 9 Biogen Idec UK 2.96
- 57 Bristol-Myers Squibb 2.90
+ 20 Getz Pharma 2.90
+ 40 Arena Pharmaceuticals 2.89
+ 7 Alcon 2.89
- 3 Allergan 2.88
- 3 Forest 2.88
- 25 Medivir Group 2.87
+ 18 Patheon 2.86
- 11 Bristol-Myers Squibb UK 2.86
+ 8 Gedeon Richter 2.85
+ 8 Pharma Nord 2.83
+ 4 Lilly UK 2.82
- 23 AEterna Zentaris 2.82
+ 18 SciClone Pharmaceuticals 2.82
+ 6 Sun Pharmaceuticals 2.81
+ 23 Nippon Kayaku 2.77
- 28 Johnson & Johnson UK 2.76
+ 28 Yakult Honsha 2.75
+ 4 Maruho 2.73
+ 4 Lupin Pharmaceuticals 2.71
- 11 Covidien 2.70
- 29 Teva Pharmaceutical Industries Ltd 2.70
+ 34 ImmunoGen 2.68
+ 20 Lavipharm 2.63
- 5 Enzon Pharmaceuticals 2.63
+ 4 Nippon Shinyaku 2.61
+ 4 Square Pharmaceuticals 2.59
- 97 Ferozsons Laboratories 2.58
+ 19 Handok 2.57
+ 17 Amgen UK 2.57
+ 2 Celgene 2.54
- 7 Enzo Biochem 2.53
+ 2 Biogen Idec 2.52
- 37 BioMarin Pharmaceutical 2.51
+ 10 Chiesi 2.51
+ 1 Pierre Fabre 2.50
+ 3 Allergan UK 2.44
- 4 Almirall Spain 2.43
- 12 Progenics Pharmaceuticals 2.42
+ 1 Sinovac Biotech 2.34
+ 8 Purdue Pharma 2.28
+ 12 Incepta Pharmaceuticals 2.28
+ 16 Sinopharm 2.24
- 106 Advaxis 2.21
+ 13 Cerus 2.11
+ 5 Ego Pharmaceuticals 2.08
- 5 Kaneka 2.07
+ 5 CSL Behring 2.02
+ 6 Myriad Genetics 1.98
- 14 Beximco Pharmaceuticals 1.91
- 38 Green Cross 1.77
same Veloxis Pharmaceuticals 1.68
+ 7 CinnaGen 1.36
+ 2 Taro Pharmaceutical Industries 1.29
+ 6 Perrigo UK 1.24